NCRCC signs agree­ment to use AI for breast can­cer di­ag­no­sis

BioSpectrum (Asia) - - Academic News -

The Na­tional Clin­i­cal Re­search Cen­ter for Can­cer (NCRCC) in China has signed a deal with the In­sti­tute of Com­put­ing Tech­nol­ogy un­der the Chi­nese Academy of Sciences (CAS) to use ar­ti­fi­cial in­tel­li­gence (AI) in med­i­cal imag­ing.

The Tian­jin Med­i­cal Univer­sity Can­cer In­sti­tute and Hospi­tal was ap­pointed as the NCRCC by the Min­istry of Science and Tech­nol­ogy of the Peo­ple’s Republic of China (PRC) in 2013. CAS is the na­tional sci­en­tific think tank and aca­demic gov­ern­ing body in the PRC and it com­prises 104 re­search in­sti­tutes, 12 branch acad­e­mies, three uni­ver­si­ties and 11 sup­port­ing or­ga­ni­za­tions in 23 pro­vin­cial-level ar­eas through­out the coun­try.

The first area of fo­cus for the co­op­er­a­tion will be to use the AI tech­nol­ogy for read­ing breast scans and mam­mo­grams, two com­mon meth­ods used in breast can­cer screen­ing. Deep learn­ing tech­nol­ogy will be used to build mod­els based on the ex­pe­ri­ence of ra­di­ol­o­gists. The ma­chine would be trained on hun­dreds of thou­sands of breast scan re­ports be­fore it as­sists the doc­tors in di­ag­no­sis. It will be able to pro­duce a highly-ac­cu­rate re­port in just a few sec­onds based on its read­ing of the scans.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.